PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Quarello E and Trabbia A High-definition flow combined with spatiotemporal image correlation in the diagnosis of fetal coarctation of the aorta. 2009 Ultrasound Obstet Gynecol pmid:19194864
Ishii T et al. Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders. 2009 Blood pmid:19196660
Passeron T et al. Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid. 2009 J. Clin. Invest. pmid:19273910
Yuan ZB et al. Temporal expression of cyclooxygenase-2 in peritoneal macrophages of rats and effects of panax notoginseng saponins. 2009 Inflamm. Res. pmid:19184357
Whelan CJ Evidence that 13-14 di-hydro, 15-keto prostaglandin D(2)-induced airway eosinophilia in guinea-pigs is independent of interleukin-5. 2009 Inflamm. Res. pmid:19184361
Liu J et al. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes. 2009 Shock pmid:19174742
Kolaczkowska E et al. Increased cyclooxygenase activity impairs apoptosis of inflammatory neutrophils in mice lacking gelatinase B/matrix metalloproteinase-9. 2009 Immunology pmid:19175797
Joo M et al. Lipopolysaccharide-dependent interaction between PU.1 and c-Jun determines production of lipocalin-type prostaglandin D synthase and prostaglandin D2 in macrophages. 2009 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:19181746
Gao W et al. Prostaglandin D(2) sustains the pyrogenic effect of prostaglandin E(2). 2009 Eur. J. Pharmacol. pmid:19249295
Wang Y et al. Peroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model. 2009 Pediatr. Res. pmid:19262292
Yamamoto M et al. Expression and characterization of PGD2 receptors in chronic rhinosinusitis: modulation of DP and CRTH2 by PGD2. 2009 Int. Arch. Allergy Immunol. pmid:18802357
Ferguson HE et al. Electrophilic peroxisome proliferator-activated receptor-gamma ligands have potent antifibrotic effects in human lung fibroblasts. 2009 Am. J. Respir. Cell Mol. Biol. pmid:19286977
Xue L et al. Interaction between prostaglandin D and chemoattractant receptor-homologous molecule expressed on Th2 cells mediates cytokine production by Th2 lymphocytes in response to activated mast cells. 2009 Clin. Exp. Immunol. pmid:19220324
Ono E et al. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis. 2009 Clin. Exp. Allergy pmid:19128354
Shin SW et al. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity. 2009 Clin. Cancer Res. pmid:19690198
Wendeburg L et al. Resveratrol inhibits prostaglandin formation in IL-1beta-stimulated SK-N-SH neuronal cells. 2009 J Neuroinflammation pmid:19751497
Ferguson HE et al. Peroxisome proliferator-activated receptor-gamma ligands induce heme oxygenase-1 in lung fibroblasts by a PPARgamma-independent, glutathione-dependent mechanism. 2009 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:19734319
Kim DH et al. Effects of 15-deoxy-delta 12, 14-prostaglandin J2 on the expression of p53 in MCF-7 cells. 2009 Ann. N. Y. Acad. Sci. pmid:19723057
Song NY et al. 15-Deoxy-delta 12, 14-prostaglandin J2 induces upregulation of multidrug resistance-associated protein 1 via Nrf2 activation in human breast cancer cells. 2009 Ann. N. Y. Acad. Sci. pmid:19723058
Cha B et al. 15-Deoxy-delta 12, 14,-prostaglandin J2 suppresses nuclear factor-kappaB-mediated apoptosis of Helicobacter pylori-infected gastric epithelial cells. 2009 Ann. N. Y. Acad. Sci. pmid:19723089
Hokari R et al. Increased expression and cellular localization of lipocalin-type prostaglandin D synthase in Helicobacter pylori-induced gastritis. 2009 J. Pathol. pmid:19768745
Urade Y [Molecular mechanisms of insomnia]. 2009 Nippon Rinsho pmid:19768929
Ma XM et al. Peroxisome proliferator-activated receptor-gamma is essential in the pathogenesis of gastric carcinoma. 2009 World J. Gastroenterol. pmid:19701967
Levy JH Biomarkers in the diagnosis of anaphylaxis: making nature disclose her mysteries. 2009 Clin. Exp. Allergy pmid:19032357
Waku T et al. Atomic structure of mutant PPARgamma LBD complexed with 15d-PGJ2: novel modulation mechanism of PPARgamma/RXRalpha function by covalently bound ligands. 2009 FEBS Lett. pmid:19101554
Selg E et al. Two different mechanisms for modulation of bronchoconstriction in guinea-pigs by cyclooxygenase metabolites. 2009 Prostaglandins Other Lipid Mediat. pmid:19103301
Dong YW et al. Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition. 2009 World J. Gastroenterol. pmid:19152448
Koinuma S et al. The resetting of the circadian rhythm by Prostaglandin J2 is distinctly phase-dependent. 2009 FEBS Lett. pmid:19111547
Baregamian N et al. PPAR-gamma agonist protects against intestinal injury during necrotizing enterocolitis. 2009 Biochem. Biophys. Res. Commun. pmid:19114032
Byrns MC and Penning TM Type 5 17beta-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs. 2009 Chem. Biol. Interact. pmid:19010312
Higdon AN et al. Methods for imaging and detecting modification of proteins by reactive lipid species. 2009 Free Radic. Biol. Med. pmid:19446632
Kar R et al. A novel role for MAP1 LC3 in nonautophagic cytoplasmic vacuolation death of cancer cells. 2009 Oncogene pmid:19448671
Zhang GY et al. Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro. 2009 Arch. Dermatol. Res. pmid:19466435
Ulbrich SE et al. Quantitative characterization of prostaglandins in the uterus of early pregnant cattle. 2009 Reproduction pmid:19470711
Shichijo M et al. A prostaglandin D2 receptor antagonist modifies experimental asthma in sheep. 2009 Clin. Exp. Allergy pmid:19486034
Wang X et al. Potential effects of peroxisome proliferator-activated receptor activator on LPS-induced lung injury in rats. 2009 Pulm Pharmacol Ther pmid:19489131
Comabella M et al. Plasma levels of 15d-PGJ are not altered in multiple sclerosis. 2009 Eur. J. Neurol. pmid:19538219
Qin HD et al. Upregulation of peroxisome proliferator-activated receptor-gamma and NADPH oxidases are involved in restenosis after balloon injury. 2009 J. Cell. Physiol. pmid:19562688
Leduc M et al. Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands. 2009 J. Pharmacol. Exp. Ther. pmid:19584306
Bai G et al. Regulation of ANP secretion from isolated atria by prostaglandins and cyclooxygenase-2. 2009 Peptides pmid:19539681
Pierre SR et al. Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice. 2009 J Neuroinflammation pmid:19630993
Pena-dos-Santos DR et al. Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint. 2009 Neuroscience pmid:19647045
Asano S et al. Effects of prostaglandin D2 on Na-dependent phosphate transport activity and its intracellular signaling mechanism in osteoblast-like cells. 2009 Prostaglandins Leukot. Essent. Fatty Acids pmid:19616422
Gao W et al. Prostaglandin D2 produced by hematopoietic prostaglandin D synthase contributes to LPS-induced fever. 2009 J. Physiol. Pharmacol. pmid:19617658
Butterfield JH Survey of aspirin administration in systemic mastocytosis. 2009 Prostaglandins Other Lipid Mediat. pmid:19429499
Moniot B et al. The PGD2 pathway, independently of FGF9, amplifies SOX9 activity in Sertoli cells during male sexual differentiation. 2009 Development pmid:19429785
Relic B et al. Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts. 2009 Lab. Invest. pmid:19434061
Jung WK et al. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1. 2009 Life Sci. pmid:19409914
Strakhova MI et al. In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory properties. 2009 Br. J. Pharmacol. pmid:19413570
Bujold K et al. CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages. 2009 Cardiovasc. Res. pmid:19377069
Mrabet-Dahbi S et al. Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. 2009 Exp. Dermatol. pmid:19382314
Tagen M et al. Mitochondrial uncoupling protein 2 inhibits mast cell activation and reduces histamine content. 2009 J. Immunol. pmid:19846869
Prakash J et al. Albumin-binding and tumor vasculature determine the antitumor effect of 15-deoxy-Delta-(12,14)-prostaglandin-J(2) in vivo. 2009 Neoplasia pmid:20019843
Khanim FL et al. Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia. 2009 PLoS ONE pmid:19997560
Pustovrh MC et al. MMP/ TIMP balance is modulated in vitro by 15dPGJ(2) in fetuses and placentas from diabetic rats. 2009 Eur. J. Clin. Invest. pmid:19811527
Piprek RP Genetic mechanisms underlying male sex determination in mammals. 2009 J. Appl. Genet. pmid:19875885
Csányi G et al. Effects of 3-aminopyridine-induced seizures on platelet eicosanoid synthesis. 2008 May-Jun Pharmacol Rep pmid:18622059
Kalogeromitros D et al. A quercetin containing supplement reduces niacin-induced flush in humans. 2008 Jul-Sep Int J Immunopathol Pharmacol pmid:18831918
Papageorgiou E et al. Rosiglitazone attenuates insulin-like growth factor 1 receptor survival signaling in PC-3 cells. 2008 Jul-Aug Mol. Med. pmid:18475308
Pettipher R and Hansel TT Antagonists of the prostaglandin D2 receptor CRTH2. 2008 Jul-Aug Drug News Perspect. pmid:18836589
Takahashi N et al. Molecular characterization of TRPA1 channel activation by cysteine-reactive inflammatory mediators. 2008 Jul-Aug Channels (Austin) pmid:18769139
Tokuda H et al. Function of Rho-kinase in prostaglandin D2-induced interleukin-6 synthesis in osteoblasts. 2008 Jul-Aug Prostaglandins Leukot. Essent. Fatty Acids pmid:18771907
Dang HT et al. New jasmonate analogues as potential anti-inflammatory agents. 2008 Bioorg. Med. Chem. pmid:18996699
Adler DH et al. Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction. 2008 J. Clin. Invest. pmid:18451993
Poncin S et al. Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content. 2008 Endocrinology pmid:17884933
Royer JF et al. A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils. 2008 Eur. J. Clin. Invest. pmid:18837743
Payne CA et al. Loss of prostaglandin D2 synthase: a key molecular event in the transition of a low-grade astrocytoma to an anaplastic astrocytoma. 2008 Mol. Cancer Ther. pmid:18852145
Moon TC and Befus AD Exogenous nitric oxide regulates cyclooxygenase-2 expression and prostaglandin D(2) generation through p38 MAPK in mouse bone marrow-derived mast cells. 2008 Free Radic. Biol. Med. pmid:18598759
Su RY et al. 15-deoxy-Delta12,14-prostaglandin J2 up-regulates death receptor 5 gene expression in HCT116 cells: involvement of reactive oxygen species and C/EBP homologous transcription factor gene transcription. 2008 Mol. Cancer Ther. pmid:18852146
Kim HY et al. Upregulation of lipopolysaccharide-induced interleukin-10 by prostaglandin A1 in mouse peritoneal macrophages. 2008 J. Microbiol. Biotechnol. pmid:18600064
Oguma T et al. Role of prostaglandin D(2) and its receptors in the pathophysiology of asthma. 2008 Allergol Int pmid:18946232
Lee SJ et al. 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis via JNK-mediated mitochondrial pathway in osteoblastic cells. 2008 Toxicology pmid:18450357
Moniot B et al. Male specific expression of lipocalin-type prostaglandin D synthase (cPTGDS) during chicken gonadal differentiation: relationship with cSOX9. 2008 Sex Dev pmid:18577876
Nagata D et al. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer. 2008 Cancer Detect. Prev. pmid:18789607
Amir-Moazami O et al. Phospholipid scramblase 1 modulates a selected set of IgE receptor-mediated mast cell responses through LAT-dependent pathway. 2008 J. Biol. Chem. pmid:18579528
Yoshimura T et al. Correlation between the prostaglandin D(2)/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma. 2008 Allergol Int pmid:18797183
Chearwae W and Bright JJ 15-deoxy-Delta(12,14)-prostaglandin J(2) and curcumin modulate the expression of toll-like receptors 4 and 9 in autoimmune T lymphocyte. 2008 J. Clin. Immunol. pmid:18463970
Maruyama T et al. Prostaglandin D(2) induces contraction via thromboxane A(2) receptor in rat liver myofibroblasts. 2008 Eur. J. Pharmacol. pmid:18586024
Zhao W et al. TGF-beta1 attenuates mediator release and de novo Kit expression by human skin mast cells through a Smad-dependent pathway. 2008 J. Immunol. pmid:18981148
Cruz-Orengo L et al. Cutaneous nociception evoked by 15-delta PGJ2 via activation of ion channel TRPA1. 2008 Mol Pain pmid:18671867
Telleria-Diaz A et al. Different effects of spinally applied prostaglandin D2 on responses of dorsal horn neurons with knee input in normal rats and in rats with acute knee inflammation. 2008 Neuroscience pmid:18678231
Kim EH and Surh YJ The role of 15-deoxy-delta(12,14)-prostaglandin J(2), an endogenous ligand of peroxisome proliferator-activated receptor gamma, in tumor angiogenesis. 2008 Biochem. Pharmacol. pmid:18771658
Kim JW et al. 15-Deoxy-Delta(12,14)-prostaglandin J(2) rescues PC12 cells from H2O2-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2. 2008 Biochem. Pharmacol. pmid:18775681
Kuehn HS et al. The phosphoinositide 3-kinase-dependent activation of Btk is required for optimal eicosanoid production and generation of reactive oxygen species in antigen-stimulated mast cells. 2008 J. Immunol. pmid:19017959
Ho TC et al. 15-deoxy-Delta(12,14)-prostaglandin J2 induces vascular endothelial cell apoptosis through the sequential activation of MAPKS and p53. 2008 J. Biol. Chem. pmid:18718914
Chearwae W and Bright JJ PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells. 2008 Br. J. Cancer pmid:19018263
Chan BC et al. Traditional Chinese medicine for atopic eczema: PentaHerbs formula suppresses inflammatory mediators release from mast cells. 2008 J Ethnopharmacol pmid:18725279
Patel P et al. Enantio- and stereospecific syntheses of 15(R)-Me-PGD2, a potent and selective DP2-receptor agonist. 2008 J. Org. Chem. pmid:18700746
Le Mée S et al. 7beta-Hydroxy-epiandrosterone-mediated regulation of the prostaglandin synthesis pathway in human peripheral blood monocytes. 2008 Steroids pmid:18555503
Lee JH et al. The 15-deoxy-delta 12,14-prostaglandin J2 suppresses monocyte chemoattractant protein-1 expression in IFN-gamma-stimulated astrocytes through induction of MAPK phosphatase-1. 2008 J. Immunol. pmid:19050284
Lian TW et al. Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages. 2008 Biochim. Biophys. Acta pmid:18662803
Jozkowicz A et al. 15d-PGJ2 upregulates synthesis of IL-8 in endothelial cells through induction of oxidative stress. 2008 Antioxid. Redox Signal. pmid:18665800
Yu JH et al. SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas. 2008 Int. J. Biochem. Cell Biol. pmid:18035585
Yokoi H et al. Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement. 2008 J. Allergy Clin. Immunol. pmid:18036650
Kuboki S et al. Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice. 2008 Hepatology pmid:18085707
Papaliodis D et al. The flavonoid luteolin inhibits niacin-induced flush. 2008 Br. J. Pharmacol. pmid:18223672
Lutzow YS et al. 15-Deoxy-Delta12,14-prostaglandin J2 induces chemokine expression, oxidative stress and microfilament reorganization in bovine mammary epithelial cells. 2008 J. Dairy Res. pmid:18226310
Torres D et al. Prostaglandin D2 inhibits the production of IFN-gamma by invariant NK T cells: consequences in the control of B16 melanoma. 2008 J. Immunol. pmid:18178816
Li W et al. Neuronal cyclooxygenase-2 activity and prostaglandins PGE2, PGD2, and PGF2 alpha exacerbate hypoxic neuronal injury in neuron-enriched primary culture. 2008 Neurochem. Res. pmid:17763946
Paruchuri S et al. Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells. 2008 J. Biol. Chem. pmid:18411276